The objective of this study was to investigate the effect of method of feeding (nipple bottle vs. esophageal tube feeder) on passive transfer of immunoglobulin (Ig) G when either a large or small volume of colostrum was fed. Newborn bull calves were removed from the dam before suckling and randomly assigned to 1 of 4 colostrum replacer (CR) treatment groups: 1.5 L (100 g of IgG) of CR fed using a nipple bottle (group 1; n = 24); 1.5 L (100 g of IgG) of CR fed using an esophageal tube feeder (group 2; n = 24); 3.0 L (200 g of IgG) of CR fed using a nipple bottle (group 3; n = 24), or 3.0 L (200 g of IgG) of CR fed using an esophageal tube feeder (group 4; n = 25). Blood samples collected at 24 h of age showed that serum IgG levels were significantly greater in calves fed large (3 L) volumes of CR compared with calves fed small (1.5 L) volumes of CR, regardless of feeding method. These differences were attributed to the larger mass of IgG ingested by calves fed 3 L of CR (200 g of IgG) compared with calves fed 1.5 L of CR (100 g of IgG). For calves fed small (1.5 L) volumes of colostrum, serum total protein (TP, g/dL), serum IgG (IgG, mg/mL), acceptable passive transfer rates (APT, %), and apparent efficiency of absorption of IgG (AEA, %) were significantly greater for calves fed with a bottle (TP = 5.3 g/dL; IgG = 12.5 mg/mL; APT = 100%; AEA = 51.1%) compared with calves fed with an esophageal tube feeder (TP = 5.0 g/dL; IgG = 9.8 mg/mL; APT = 41.7%; AEA = 40.5%). However, for calves fed large (3 L) volumes of colostrum, there was no difference in passive transfer indices for calves fed with a bottle (TP = 5.8 g/dL; IgG = 19.7 mg/mL; APT = 100%; AEA = 41.1%) compared with calves fed with an esophageal tube feeder (TP = 5.9 g/dL; IgG = 18.7 mg/mL; APT = 100%; AEA = 39.0%).
The design, synthesis, and biological characterization of an orally active prodrug (3) of gemcitabine are described. Additionally, the identification of a novel co-crystal solid form of the compound is presented. Valproate amide 3 is orally bioavailable and releases gemcitabine into the systemic circulation after passing through the intestinal mucosa. The compound has entered clinical trials and is being evaluated as a potential new anticancer agent.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.